top of page

EASE

 NOW IN SCHIZOPHRENIA RESEARCH

The Laitman's published paper:

..The EASE model for optimum use of clozapine: A clinician perspective..

HealthFirst

 Dr. Laitman will present  Transforming Care for Individuals Living with Psychosis

on Healthfirst’s network on 10/12.  Healthfirst is a not-for-profit Managed Care Plan

(primarily Medicaid and Medicare)

NAMI SWCT

​ Dr. Rob Laitman held a ZOOM on

Feb 16, 2023

Optimal Treatment of Psychotic Disorders: Clozapine/Engagement/Community 

TD CLOZAPINE REGIMEN & MAINTENANCE SUMMARY

A detailed reference for doctors and caregivers new to clozapine

who are trying to maximize efficacy while minimize side effects. 

TD CLOZAPINE SIDE EFFECTS

At-A-Glance: Side effects, treatments and helpful hints for amelioratation.

ATHELAS INFORMATION

Application for Clozaril Program / Golden Gate Pharmacy Services

VIRTUAL HARVARD

SLIDES PART l  &  SLIDES PART ll

On March 16,  2022 Dr. Rob Laitman did

 Harvard Psychiatric Grand Rounds entitled

Optimal Treatment of Psychotic Disorders: Clozapine/Engagement/Community

PRESENTATION on Youtube  

SCHIZOPHRENIA: THREE MOMS IN THE TRENCHS

PODCAST: Rethinking Clozapine: Should it be the First Resort to Treat Schizophrenia? 

Dr Laitman discusses Clozapine with Randye Kaye, Mindy Greiling and Mimi Feldman - June, 2021

Reform HIPAA’s Privacy Rule for the sake of treating the most severely mentally ill. Written for the Treatment Advocacy Center in March, 2021

Insight into the mental healthcare funding challenges that our country faces.

December, 2020

NAMICon 2021

PART l  &  PART ll

Dr. Rob Laitman presented a virtual NAMI workshop on July 27 focusing on:

Optimal Treatment of Psychotic Disorders: Clozapine/Engagement/Community 

Schizophrenia - My Definition

Unpacking Schizophrenia:

Dr.Laitman & Consultant 360 Podcasts

Preventing Suicide 1/19/19

Dr.Laitman's Documents

bottom of page